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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYPrimordial germ cells (PGCs) are lineage-restricted unipotent cells that can dedifferentiate into pluripotent embryonic germ cells (EGCs).
Here we performed whole-transcriptome analysis during the conversion of PGCs into EGCs, a process by which cells acquire pluripo-
tency. To examine the molecular mechanism underlying this conversion, we focused on Blimp-1 and Akt, which are involved in PGC
specification and dedifferentiation, respectively. Blimp-1 overexpression in embryonic stem cells suppressed the expression of down-
stream targets of the pluripotency network. Conversely, Blimp-1 deletion in PGCs accelerated their dedifferentiation into pluripotent
EGCs, illustrating that Blimp-1 is a pluripotency gatekeeper protein in PGCs. AKT signaling showed a synergistic effect with basic fibro-
blast growth factor plus 2i+A83 treatment on EGC formation. AKT played a major role in suppressing genes regulated by MBD3. From
these results, we defined the distinct functions of Blimp-1 andAkt and providedmechanistic insights into the acquisition of pluripotency
in PGCs.INTRODUCTION
Germ cells are the only cells that continue to be reprog-
rammed throughout their lifetime in order to transfer ge-
netic information to subsequent generations (Sasaki and
Matsui, 2008). Germ cells have unique characteristics such
as genome-wide epigenetic reprogramming and the poten-
tial to become pluripotent (Saitou and Yamaji, 2012). Pri-
mordial germ cells (PGCs) are specified at embryonic day
(E) 7 in the epiblast. Blimp-1, Prdm14, and Tfap2c have crit-
ical roles in the specification of PGCs. A functional study
of knockout embryos showed that BLIMP-1 represses so-
matic genes (Ohinata et al., 2005), whereas PRDM14 acti-
vates germ cell development genes (Yamaji et al., 2008).
Tfap2c is thought to be a functional downstream target of
BLIMP-1 (Weber et al., 2010). These three factors are suffi-
cient to induce PGCs in vitro (Nakaki et al., 2013). Germ
cell development, especially PGC specification, shares simi-
larities with somatic cell reprogramming. Factors involved
in germ cell development also function in the reprogram-
ming of somatic cells (Nagamatsu et al., 2011). Moreover,
PGCs have the potential to dedifferentiate into pluripotent
embryonic germ cells (EGCs) without exogenous gene acti-
vation (Matsui et al., 1992). Although pluripotent stem cells
and PGCs share many common features, PGCs are unipo-
tent germ lineage-restricted cells and are distinct from
pluripotent stem cells. When injected into blastocysts,
PGCsdonotgive rise toanycell lineages (Leitchet al., 2014).StemOriginally, EGCs were established thorough screening
of the culture conditions required for PGC proliferation
(Matsui et al., 1992). Basic fibroblast growth factor
(bFGF), leukemia inhibitory factor (LIF), and membrane-
bound stem cell factor (mSCF) are present under these
culture conditions. Because activation of phosphoinosi-
tide-3-kinase and AKT signaling negates the requirement
for bFGF in such cultures, Akt is known to be involved
in the induction of pluripotency in PGCs (Kimura et al.,
2008). Recently, it was reported that a combination of
signaling inhibitors enhances the efficiency of EGC for-
mation (Leitch et al., 2010; Nagamatsu et al., 2012a).
These inhibitors consist of 2i inhibitors (inhibitors of
mitogen-activated protein kinase kinase [MEK] and
glycogen synthase kinase-b), which maintain pluripo-
tency, and A83 (an inhibitor of transforming growth
factor-b receptor), which enhances somatic cell reprog-
ramming (Ying et al., 2008; Yuan et al., 2011). However,
the mechanisms underlying the induction of pluripo-
tency in PGCs remain largely elusive. While only germ
cells can give rise to pluripotent cells following implanta-
tion, induced pluripotent stem cell (iPSC) technology en-
ables pluripotent cells to be established from somatic cells
(Takahashi and Yamanaka, 2006). Methyl-CpG binding
domain protein 3 (Mbd3) was recently identified as a
roadblock of somatic cell reprogramming (Rais et al.,
2013). MBD3 is a component of the nucleosome remodel-
ing deacetylase (NuRD) complex, which has histoneCell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 111
deacetylase activity and serves to close the chromatin
structure (Hu and Wade, 2012).
In this study, we performed extensive gene expression
analysis during the dedifferentiation of PGCs into EGCs
and combined these data with the data for previously pub-
lished target gene sets. Extensive analysis of transcription
profiles revealed that BLIMP-1 suppressed pluripotency
network genes andwas therefore a pluripotency gatekeeper
protein in PGCs. Moreover, there was a synergistic effect of
AKTactivation in the presence of bFGF and 2i+A83 on EGC
formation. AKT activation suppressed genes regulated by
MBD3. The targets of AKT and BLIMP-1 were different.
Taken together, these results provide insight into themech-
anism by which PGCs are converted into EGCs.RESULTS
Transcriptome Analysis during the Conversion of
PGCs into Pluripotent Stem Cells
To elucidate the molecular mechanisms by which PGCs
become pluripotent cells, we performed whole-transcrip-
tome analysis during the conversion of PGCs into EGCs.
To obtain precise data, we used specific culture conditions
for purified pluripotent candidate cells as previously re-
ported (Figure 1A) (Nagamatsu and Suda, 2013). Heatmap
and principal component analysis (PCA) indicated that
the acquisition of pluripotency in PGCs is a stepwise pro-
cess (Figures 1B and 1C). Table S1 shows the various genes
that are gradually upregulated and downregulated during
the conversion process. Gene Ontology (GO) analysis indi-
cated that the transcription of genes involved in processes
such as ‘‘transcription, DNA-dependent’’ and ‘‘regulation
of transcription, DNA-dependent’’ was upregulated, while
the transcription of genes involved in ‘‘protein-chromo-
phore linkage’’ was downregulated (Table S1). To under-
stand the global changes in gene expression during the
acquisition of pluripotency, we compared the numbers of
differentially expressed genes at each time point of the cul-
ture (Figure 1D). There were two waves observed by differ-
entially expressed genes. The first wave was from day 0 to
day 1, and the second wave was from day 6 to day 10.
When these differentially expressed genes were divided
into upregulated or downregulated genes, most genes in
the first wave were upregulated, and most genes in the sec-
ond wave were downregulated (Figure 1E). Moreover, more
than half of the genes upregulated in the first wave were
downregulated in the second wave (Figure 1F; Table S1),
indicating that they were oppositely regulated during
these time periods. When we focused on these genes, GO
analysis revealed the enrichment of terms associated
with the ‘‘cell cycle,’’ ‘‘development,’’ and ‘‘metabolism’’
(Table S1).112 Stem Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The AuthorNext, we analyzed the characteristic gene expression of
PGCs. Gene set enrichment analysis (GSEA) showed that
PGCmarkers were downregulated from day 2 of the culture
(Figure 1G). This indicated that the PGC characteristics
were lost in the early phase of pluripotency acquisition.
Analysis of the Core Transcription Network Involved
in the Conversion of PGCs into Pluripotent Stem Cells
To analyze gene expression in pluripotent candidate cells
(Nagamatsu et al., 2012a), we focused on downstream tar-
gets of the core transcription network (Kim et al., 2008).
Because PGCs express key transcription factors of pluripo-
tent stem cells, such asOct3/4, Sox2, andNanog (Nagamatsu
et al., 2013), it would be difficult to understand the differ-
ences between pluripotent stem cells and PGCs from the
expression of these key factors themselves. In fact, with
the exception ofDax1, the expression levels of the key plu-
ripotency core network did not fluctuate during the acqui-
sition of pluripotency (Figure S1). Therefore, we focused on
the gene expression changes in the downstream targets of
the core transcription network. We collected target gene
sets from previous reports and applied these data to the
GSEA of our time course gene expression profiles (Fig-
ure 2A) (Kim et al., 2008). Whereas the target genes of
OCT3/4 tended to be repressed until EGCs formed, the tar-
gets of other core network factors were maintained or grad-
ually upregulated during the conversion of PGCs into EGCs
(Figure 2A). To evaluate the changes of this network, we
calculated the numbers of genes commonly regulated by
various network factors (Figure 2B). Some of these
commonly regulated genes were involved in the process
of pluripotency acquisition. Genes regulated by multiple
factors of the core network are generally active in embry-
onic stem cells (ESCs), and these factors may be important
in self-renewal and lineage commitment (Kim et al., 2008;
Jeong et al., 2001). Therefore, we focused on genes that
shared more than seven of nine regulatory factors in com-
mon (Table S2). Most of these genes that were activated in
the early stage of the culture were also implicated in the late
stage. Seven of ten genes involved in both the early (before
day 3) and late (after day 6) culture stages encoded DNA-
binding proteins involved in the control of transcription
and/or chromatin remodeling (Klf9, Dido1, Rarg, Trim8,
Mybl2, Zfp207, and Chd9). Such factors might function as
a hub for the gene expression of other components of the
core network.
The PGC-Specific Gene Blimp-1 Represses
Downstream Targets of Pluripotency Network Genes
Microarray data of the conversion of PGCs into EGCs
revealed an inverse correlation between certain PGC char-
acteristics and pluripotent characteristics. We speculated
that there is a mechanism that suppresses pluripotents
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Figure 1. Microarray Analysis of the Acquisition of Pluripotency in PGCs
(A) Summary of the procedure used to culture cells and isolate samples. Gonads were surgically isolated from E11.5 embryos. After making a
single cell suspension, PGCs were isolated based on SSEA-1 expression using a FACS AriaII cell sorter. Purified PGCs were seeded onto m220
feeder cells in ESC medium containing bFGF. One day after seeding, 2i+A83 was added to the culture. At day 3 of culture, the cells were
reseeded onto STO feeder cells. At day 7 of culture, bFGF and 2i+A83 were removed by changing the medium. Colonies were picked, and EGC
lines were established. At each time point, pluripotent candidate cells were sorted based on stage-specific embryonic antigen-1 (SSEA-1)
expression for microarray analysis (Nagamatsu and Suda, 2013). 2i+A83 was composed of inhibitors of MEK (PD325901), glycogen syn-
thase kinase-b (CHIR99021), and transforming growth factor-b type 1R (A83-01).
(B) Array heatmap of differentially expressed genes according to the culture period.
(C) Principle component analysis during the acquisition of pluripotency in PGCs.
(D) The number of differentially expressed genes at each adjacent time point.
(E) The numbers of upregulated and downregulated genes at each adjacent time point.
(F) The numbers of oppositely regulated genes at day 0 versus day 1 and day 6 versus day 10 during the acquisition of pluripotency. The
bars indicate the total number of genes at each time point. Red indicates common genes at day 0 versus day 1 or day 6 versus day 10. The
percentage of common genes is shown below each bar. DN, downregulated; UP, upregulated.
(G) GSEA of the PGC markers.
See also Table S1.characteristics in PGCs. To investigate this possibility, we
performed microarray analysis of ESCs, which expressed
each germ gene. First, we selected six genes that are prefer-
entially expressed in PGCs rather than in ESCs, namely,
Prdm14,Vasa,Nanos2,Nanos3,Dnd, andBlimp-1 (Figure3A)Stem(Yamaji et al., 2008; Tanaka et al., 2000; Suzuki et al., 2007,
2008; Youngren et al., 2005; Ohinata et al., 2005). We
generated ESCs that expressed PGC genes under the con-
trol of doxycycline (Masui et al., 2005). We could not
obtain a stable clone of inducible Blimp-1-expressingCell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 113
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Figure 2. GSEA of Downstream Targets
(A) GSEA of downstream targets of the pluripotency network from Kim et al. (2008).
(B) The numbers of involved genes (blue), genes shared with a previous time point (green), and common genes (red) of the GSEA.
See also Figure S1 and Table S2.ESCs; therefore, Blimp-1-overexpressing cells were analyzed
by transfection of ESCs with the Blimp-1-IRES-AcGFP vector
and sorting of GFP-positive cells by fluorescence-activated
cell sorting (FACS). Gene expression levels were confirmed
by RT-PCR (Figure 3B). Microarray data were integrated
with previously reported pluripotency network targets as
shown in Figure 2A. Prdm14 is essential for germ cell spec-
ification and themaintenance of ESC pluripotency (Yamaji
et al., 2013). When Prdm14 was overexpressed in ESCs,
downstream targets of the pluripotency network were acti-
vated (Figure 3C). Similarly, expression of the other four
germ cell-specific genes (Vasa, Nanos2, Nanos3, and Dnd)
activated these downstream targets (Figure 3C). However,
when Blimp-1 was overexpressed in ESCs, the downstream
targets were clearly repressed (Figure 3C). These results sug-
gest that pluripotency suppression is not achieved by the
cooperation of multiple germ cell factors; rather, Blimp-1114 Stem Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authorappears to function as a pluripotency gatekeeper protein
in PGCs.
Identification of a Blimp-1 Module in ESCs
To understand the mechanism by which BLIMP-1 sup-
presses downstream targets of the pluripotency network,
we attempted to identify BLIMP-1 targets in ESCs.
Recently, BLIMP-1-regulated genes were identified by chro-
matin immunoprecipitation (ChIP)-sequencing analysis of
BLIMP-1 in PC19 pluripotent embryonic carcinoma cells
(Magnu´sdo´ttir et al., 2013). These BLIMP-1-regulated genes
were projected to pluripotency controlling modules of
CoORE, Polycomb (PRC), and MYC (Kim et al., 2010). In
total, 4,808 unique genes were identified from BLIMP-1
ChIP-sequencing analysis and were included in the mod-
ules. We referred to these putative BLIMP-1 targets in
ESCs as the BLIMP-1 modules (Figure 4A). Among thes
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Figure 3. Blimp-1 Represses Downstream Targets of Pluripotency Network Genes
(A) Gene expression of the germ cell markers is shown. Expression in E11.5 PGCs was compared with that in ESCs (TT2). Relative gene
expression is shown (mean ± SD; independent experiments, n = 3). Red bars indicate the expression level in ESCs (set at 1).
(B) Gene expression of germ cell markers in ESCs. The expression in overexpressing ESCs was compared with that in parental ESCs. Relative
gene expression is shown (mean ± SD; independent experiments, n = 3). Red bars indicate the expression level in parental ESCs (set at 1).
In the case of Blimp-1, expression in ESCs transfected with Blimp-1-IRES-AcGFP was compared with that in ESCs transfected with IRES-
AcGFP. Red bars indicate the expression level in ESCs transfected with IRES-AcGFP (set at 1).
(C) GSEA of downstream targets of the pluripotency network from Kim et al. (2008). ESCs overexpressing each germ cell gene were
compared with parental ESCs. In the case of Blimp-1, ESCs were transfected with pEF1a-IRES-AcGFP or EF1a-Blimp-1-IRES-AcGFP, and then
AcGFP-positive cells were sorted and compared.CORE, PRC, and MYC modules, about 40% of genes be-
longed to the BLIMP-1 module (Figures 4B and 4C). Next,
the BLIMP-1 module was applied to our microarray data
from Blimp-1-overexpressing ESCs. When Blimp-1 was
overexpressed in ESCs, the majority of BLIMP-1 module
genes were downregulated, while about 10% of genes
were upregulated (Figure 4D). Most of these upregulated
genes were collectively classified as a PRC module (Figures
4E–4G). In ESCs, whereas CORE andMYCmodules are acti-
vated, PRC modules are suppressed (Kim et al., 2010).StemTherefore, Blimp-1 likely suppressed pluripotency through
a BLIMP-1 module.
Blimp-1 Depletion Induces Pluripotency in PGCs
To clarify the functional role of Blimp-1 in pluripotency
acquisition in PGCs, we deleted Blimp-1. First, we purified
PGCs from Blimp-1-floxed mouse embryos and then used
recombinant CRE protein to delete Blimp-1 (Ohinata
et al., 2005). CRE-treated PGCs were seeded onto STO or
m220 feeder cells without bFGF. In the absence of bFGF,Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 115
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Figure 4. Identification of Blimp-1 Modules in ESCs
(A) Summary of the identification of BLIMP-1 modules in ESCs. BLIMP-1 targets were obtained from the ChIP-sequencing data of Mag-
nu´sdo´ttir et al. (2013) (right). The 4808 BLIMP-1-regulated genes targets were projected to each regulated module of ESCs reported by Kim
et al. (2010) (left). These overlapped genes were identified as individual BLIMP-1 modules.
(B) The numbers of BLIMP-1 target genes in each regulated module of ESCs.
(C) Percentage of BLIMP-1 target genes in each regulated module of ESCs.
(D) Percentage of upregulated and downregulated BLIMP-1 targets in ESCs at day 2.
(E) Numbers of upregulated genes in each BLIMP-1 module in Blimp-1-overexpressing ESCs at day 2.
(F) Numbers of downregulated genes in each BLIMP-1 module in Blimp-1-overexpressing ESCs at day 2.
(G) Percentage of upregulated and downregulated genes in each BLIMP-1 module in Blimp-1-overexpressing ESCs at day 2. DN, down-
regulated; UP, upregulated.PGCs could not convert to EGCs (Durcova-Hills et al.,
2006). m220 feeder cells express mSCF, which is an impor-
tant signal for EGC formation (Matsui et al., 1992). After
culture, ESC-like colonies formed from Blimp-1-deleted
PGCs grown on both types of feeder cells (Figures 5A–
5C). Blimp-1 deletion was confirmed by genomic PCR (Fig-
ure S2A). Additional treatment with 2i+A83, which
enhances EGC generation (Nagamatsu et al., 2012a), also
enhanced the efficiency with Blimp-1 deletion. On the
other hand, in the presence of bFGF, the efficiency was
decreased. These results indicated that there is no synergis-
tic effect between Blimp-1 deletion and bFGF. The gene116 Stem Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authorexpression pattern in Blimp-1-deleted ESC-like colony cells
indicated that the lack of Blimp-1 induced the upregulation
of Klf4 and ERas (Figure 5D). When injected into nude
mice, these established ESC-like cells formed teratomas
containing three germ layers (Figures 5E and 5F), reminis-
cent of pluripotent stem cells. These results indicate that
Blimp-1 deletion causes PGCs to becoming pluripotent. In
the next experiment, rather than deleting Blimp-1, we
induced the forced expression of Blimp-1 in PGCLCs during
EGC formation. PGCLCs are in vitro-induced PGCs from
ESCs (Hayashi et al., 2011). In this study, we established
these cells using doxycycline inducible Blimp-1-expressings
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Figure 5. Blimp-1 Depletion Induces Pluripotency in PGCs
(A) Typical morphology of embryonic stem cell (ESC)-like colonies after Blimp-1 depletion by CRE treatment and culture on feeder cells
(m220 or STO). A primary colony at day 10 of culture and an established line are shown. Scale bars 100 mM (top) and 500 mM (bottom).
(B and C) The number of ESC-like colonies observed 10 days after Blimp-1 deletion by CRE treatment and culture on m220 (B) or STO (C)
feeder cells with or without 2i+A83 treatment. Data represent the mean ± SD of independent experiment. Statistical significance was
determined using Tukey’s multiple comparison test (n = 5 for no treatment on m220, n = 4 for 2i+A83 on m220, n = 5 for bFGF + 2i+A83,
n = 10 for no treatment on STO and n = 4 for 2i+A83 on STO). **p < 0.01, *p = 0.019.
(D) Gene expression analyses of Blimp-1-depleted EGCs for Blimp-1 (left), Klf4 (middle), and ERas (right) are shown (mean ± SD; inde-
pendent experiments, n = 3).
(E and F) Teratoma formation by Blimp-1-depleted EGCs induced on m220 (E) or STO (F) feeder cells, with or without 2i+A83 treatment.
Scale bars represent 50 mM.
(G) GSEA of BLIMP-1 targets for the microarray time course data. BLIMP-1 modules are the gene sets identified in Figure 4. rCRE, re-
combinant CRE.
See also Figure S2.ESCs (Nakaki et al., 2013). When Blimp-1 was induced at
the early phase of the EGC formation, PGCLCs could not
convert to EGCs (Figure S2B). To confirm the effect of
BLIMP-1 modules during the acquisition of pluripotency
in PGCs, we analyzed expression changes of BLIMP-1mod-
ules in the time course transcriptome data. Whereas the
BLIMP-1 modules of CORE and MYC were activated, the
BLIMP-1 module of PRC was suppressed (Figure 5G). These
changes correspond to the regulation in ESCs, suggestingStemthat the BLIMP-1 modules are of functional relevance dur-
ing EGC formation (Kim et al., 2010). Taken together, these
results show that Blimp-1 acted as a gatekeeper of pluripo-
tency in PGCs.
AKT Has a Synergistic Effect with bFGF and 2i+A83 on
the Acquisition of Pluripotency
Next, we analyzed the key signaling required for the acqui-
sition of pluripotency in PGCs. Whereas bFGF is anCell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 117
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Figure 6. Synergistic Effect of AKT Activation Together with bFGF and 2i+A83 Treatment
(A) E11.5 PGCs were purified based on SSEA-1 expression. PGCs were seeded onto STO feeder cells in ESC medium containing 4-hydrox-
ytamoxifen (4OHT) with or without 2i+A83. The numbers of ESC-like colonies at day 10 are shown. Data represent the mean ± SD of
independent experiments. Statistical significance was determined using Student’s t test (n = 3). *p = 0.047.
(B) GSEA of AKT targets for the microarray time course data. AKT targets were identified by comparison with the data of Yamano et al.
(2010).
(C) Number of AKT targets in Blimp-1 modules. The bars indicate the total number of genes in each Blimp-1 module (Figure 4A). Red
indicates AKT target genes.
(D) Number of AKT targets among all BLIMP-1 targets (Magnu´sdo´ttir et al., 2013).
(E) Number of AKT targets in regulated modules of ESCs (Kim et al., 2010).
(F) The number of colonies at day 10 of the culture (top) and alkaline phosphatase (ALP) staining (bottom) are shown. Scale bar represents
7 mM (top). E11.5 PGCs were collected from AKT-Mer embryos based on SSEA-1 expression and induced to undergo conversion into EGCs by
culture in ESC medium containing the specified chemicals. Data represent the mean ± SD of independent experiments. Statistical sig-
nificance was determined using Tukey’s multiple comparison test (n = 3). **p < 0.01.
(G) (Left) Typical morphology of ESC-like colonies derived from AKT-Mer PGCs at day 8. SSEA-1-positive PGCs were cultured in N2B27
medium containing bFGF, 4OHT, and 2i or 2i+A83 without feeder cells or serum replacement (KSR). The lower panels are higher magni-
fication images of the upper panels. Scale bars represent 250 mM (top) and 100 mM (bottom). (Right) The number of colonies at day 8. Data
represent the mean ± SD of independent experiments. Statistical significance was determined using Student’s t test (n = 4). *p = 0.088.essential signal for the generation of EGCs fromPGCs (Dur-
cova-Hills et al., 2006), AKTactivation has been reported to
be sufficient to induce EGCs (Kimura et al., 2008). To
analyze the effect of AKT activation, we used PGCs from
Akt-mer Tg mice (Kimura et al., 2008). In these mice, AKT
is activated by adding 4OHT.We found that AKTactivation118 Stem Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authorinduced EGCs from PGCs in the absence of bFGF (Fig-
ure 6A). To analyze the AKT signal, we collected AKT target
molecules in ESCs from a previous report (Yamano et al.,
2010). When the expression profiles of AKT targets were
applied to our time course gene expression data, the AKT
targets were shown to be activated fromday 1 of the cultures
(Figure 6B). These results indicated that the AKT targets
were activated during pluripotency acquisition. Next,
we analyzed AKT and other target genes. In the
BLIMP-1modules, the AKT targets did not largely overlap
(overlap was highest in the BLIMP-1 PRC module, at
11.11%) (Figure 6C). In addition, all BLIMP-1 targets shared
few targets with AKT (Figure 6D). Moreover, all ESC mod-
ules shared a few common targets with AKT (Figure 6E),
suggesting that the effect of AKTactivation on the dediffer-
entiation of PGCs is independent of BLIMP-1 targets or ESC
modules. On the other hand, AKT activation is known to
enhance the formation of EGCs from PGCs in the presence
of bFGF (Kimura et al., 2008). In addition, although AKT
activation induced EGCs in the absence of bFGF in the pre-
sent study, 2i+A83 treatment enhanced the efficiency of
this process (Figure 6A). We speculated that AKT has addi-
tive or synergistic effects with bFGF and/or 2i+A83. There-
fore, we analyzed the combinatorial effect of bFGF, 2i+A83,
and AKTactivation.We found that AKTactivation strongly
enhanced EGC formation in the presence of bFGF and
2i+A83 (Figure 6F). Thus, AKT activation, bFGF, and
2i+A83 have a synergistic effect on the acquisition of plu-
ripotency in PGCs. This combination of signals allowed
us to generate EGCs even in the absence of feeder cells,
serum, and serum replacement (KSR) (Figure 6G).
AKT Enhances the Acquisition of Pluripotency by
Suppressing Mbd3
To understand how AKT signaling enhanced the acquisi-
tion of pluripotency in PGCs, we performed a whole-tran-
scriptome analysis of cells subjected to each combination
of treatments (Figure 7A). Inactivation of Mbd3 was
recently reported to greatly enhance the efficiency of re-
programming (Rais et al., 2013). This previous study iden-
tified the target genes of MBD3 by ChIP sequencing in
untreated mouse embryonic fibroblasts (MEFs) and those
transduced with four reprogramming factors (Oct3/4,
Sox2, Klf4, and c-Myc, hereafter referred to as OSKM). We
analyzed the expression profiles of these MBD3 target
genes in the microarray data (Figure 7B). The heatmap re-
sults clearly showed that AKT signaling suppressed the
MBD3 targets of OSKM-transduced MEFs. This tendency
was also observed for the MBD3 targets of untreated
MEFs (Figures S3A–S3D). To understand the function of
the MBD3 targets of OSKM-transduced MEFs in PGCs, we
analyzed the overlap between MBD3 targets and BLIMP-1
target genes. MBD3 targets in OSKM-transduced MEFs
shared few targets with the BLIMP-1 modules or with all
BLIMP-1 targets (Figures 7C and 7D). In addition, the ESC
modules did not overlap with the MBD3 targets of
OSKM-transduced MEFs (Figure 7E). Moreover, when look-
ing at the microarray data of PGCs subjected to various
treatments, we found that AKT activation was not corre-Stemlated with the changes in BLIMP-1 modules that accompa-
nied EGC generation, namely, activation of the Core and
Myc modules and suppression of the PRC module (Fig-
ure 7F). Taken together, these findings showed that AKT
activation suppressed the MBD3 targets of OSKM-trans-
duced MEFs in PGCs, which were different from the down-
stream targets of the BLIMP-1 and ESCmodules. Finally, we
analyzed whether AKT activation also downregulates
MBD3 during somatic cell reprogramming. We found
that, following the activation of AKT, MBD3 expression
was suppressed in MEFs (Figures 7F and S3E). Furthermore,
AKTactivation at the early phase of somatic cell reprogram-
ming enhanced the efficiency of this process (Figure 7H).
Therefore, AKT activation enhanced pluripotency acquisi-
tion inMEFs via the suppression of MBD3-regulated genes.DISCUSSION
We have identified that Blimp-1 functions as a gatekeeper
of pluripotency in PGCs. Blimp-1 was originally identified
as a transcriptional repressor in B cell maturation (Turner
et al., 1994). During PGC specification, BLIMP-1 is impor-
tant for the suppression of somatic cell programming (Kur-
imoto et al., 2008). The targets of BLIMP-1 may differ
according to the situation. Transcription factors change
the targets in a cell state-dependent manner. For example,
Niwa et al. reported that the targets of SOX2 differed be-
tween ESCs and trophoblast stem cells because of different
binding partners (Adachi et al., 2013). It is reported that
BLIMP-1 binds the histone deacetylases TLE1 and EHMT2
in a context-dependent manner (Bikoff et al., 2009). It
would be interesting to analyze the binding partners of
BLIMP-1 during the specification of PGCs and induction
of EGCs.
Whereas we found that Blimp-1 deletion induced plurip-
otency in PGCs, the effects of Blimp-1 overexpression in
pluripotent cells appear to be more complicated. Forced
expression of Blimp-1 in ESCs induces growth retardation
(Nagamatsu et al., 2011). During PGC induction from
ESCs, induction of an intermediate cell state, namely
epiblast-like cells (EpiLCs), is important (Hayashi et al.,
2011). The combination of transcription factors Prdm14,
Blimp-1, and Tfap2c is critical to induce PGCs from EpiLCs
(Nakaki et al., 2013). However, forced induction of these
three factors cannot induce PGCs directly from ESCs.
Furthermore, whereas Prdm14 alone can induce PGCs
with low efficiency, Blimp-1 alone cannot even induce
PGCs from EpiLCs. Overexpression of Prdm14 in ESCs en-
hances pluripotency maintenance but does not induce
PGC differentiation (Okashita et al., 2014). These facts
reveal that there are important differences between ESCs
and EpiLCs in relation to PGC induction. One suchCell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 119
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Figure 7. AKT Activation Suppresses Mbd3
(A–F) Summary of the procedure used to culture cells and isolate samples for microarray analysis (B–F). Gonads were surgically isolated
from E11.5 AKT-mer embryos. After making a single cell suspension, PGCs were isolated based on SSEA-1 expression using a FACS AriaII cell
sorter. Purified PGCs were seeded onto m220 feeder cells in ESC medium containing bFGF. One day after seeding, the indicated chemicals
were added. On day 2, pluripotent candidate cells were sorted based on SSEA-1 expression for microarray analysis (Nagamatsu and Suda,
2013). 2i comprised inhibitors of MEK and glycogen synthase kinase-b (GSK3-b). A83 indicates the transforming growth factor-b (TGF-b)
type 1R inhibitor. (B) Array heatmap analysis for pluripotent candidate cells at day 2 of each treatment. Mbd3 and Mbd3 targets of MEFs in
which four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc [OSKM]) were transduced are shown. These target genes are from Rais
et al. (2013). (C) The number of MBD3 targets of OSKM-transduced MEFs in BLIMP-1 modules. Bars indicate the total number of genes in
each BLIMP-1 module (Figure 4A). Red indicates MBD3 target genes of OSKM-transduced MEFs. (D) Number of MBD3 targets of OSKM-
transduced MEFs among all BLIMP-1 targets (Magnu´sdo´ttir et al., 2013). (E) Number of MBD3 targets of OSKM-transduced MEFs in ESC
module (Kim et al., 2010). Bars indicate the total number of genes in each regulated module of ESCs. Red indicates MBD3 target genes of
OSKM-transduced MEFs. (F) GSEA of BLIMP-1 targets for pluripotent candidate cells at day 2 of each treatment. BLIMP-1 modules were the
gene sets identified in Figure 4.
(G) Western blotting of MBD3 after 4-hydroxytamoxifen (4OHT) treatment of MEFs isolated from WT and Akt-mer embryos. MEFs were
treated with 4OHT (100 nM). At the indicated time points, MEFs were harvested and MBD3 expression was analyzed by western blot.
(H) The number of 3F (Oct3/4, Sox2 and Klf4)-induced ESC-like colonies formed from Akt-mer MEFs, with or without 4OHT treatment at day
22. 4OHT was added at day 2 and allowed to react until day 6 after the 3F induction. Data represent the mean ± SD of independent
experiments. Statistical significance was determined using Student’s t test (n = 6). **p < 0.01.
(I) Gene expression regulation of cellular dynamics in the process of the acquisition of pluripotency in PGCs. Events identified in both the
current study and a previous study (Nagamatsu et al., 2012a) are shown. The efficient dedifferentiation of Mbd3 deficient PGCs was
previously reported (Rais et al., 2013).
See also Figure S3.
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difference is the existence of a suppressive mechanism in
ESCs. Recently, it was reported that inactivation ofMyc in-
duces upregulation of germ cell marker genes in ESCs
(Maeda et al., 2013). This indicates that PGC induction is
suppressed in ESCs. However, in that report, Vasa was ex-
pressed much earlier than in vivo, and early markers,
such as Blimp-1, were not activated efficiently. Therefore,
it is unclear whether Myc inactivation induces functional
differentiation. It would be intriguing to analyze differ-
ences between ESCs and EpiLCs in relation to the prerequi-
sites for PGC differentiation.
To our surprise, overexpression of Dnd enhanced down-
stream targets of pluripotency (Figure 3).WhenDnd is inac-
tivated, the number of PGCs is decreased but basal PGCs
give rise to teratomas in vivo (Youngren et al., 2005). Tera-
tomas contain three germ layers generated by pluripotent
cells. Therefore, deletion of Dnd leads to pluripotency in
PGCs. However, in the present work, Dnd did not appear
to mediate the suppression of pluripotency in ESCs. Dnd
is not a target gene of either BLIMP-1 or AKT (Dataset S1),
indicating that Dnd is regulated differently from BLIMP-1
or AKT. The mechanisms underlying pluripotency acquisi-
tion upon Dnd deletion, and the relationship between Dnd
and Blimp-1 or Akt in PGCs is an important issue to be
investigated.
In this study, we found a synergistic effect of AKT activa-
tion in the presence of bFGF and 2i+A83 on the acquisition
of pluripotency. AKT activation suppressed MBD3-regu-
lated genes in PGCs (Figure 7B). Furthermore, AKT activa-
tion downregulated MBD3 in MEFs (Figure 7G). Both AKT
activation andMBD3 inactivation have been shown to pre-
vent differentiation of ESCs in the absence of LIF (Wata-
nabe et al., 2006; Kaji et al., 2006). It is conceivable that
AKT downregulates MBD3 and thereby maintains pluripo-
tency in the absence of LIF.Mbd3 is a roadblock of pluripo-
tency (Rais et al., 2013). However, the regulation of Mbd3
expression is poorly understood. It would be interesting
to analyze how AKT signaling downregulates Mbd3.
It has been reported that a histone deacetylase (HDAC)
inhibitor had a positive effect on EGC formation.We there-
fore analyzed AKT activation and HDAC target genes. For
this purpose, we determined the genes that were upregu-
lated in Hdac-deficient ESCs (Jamaladdin et al., 2014).
GSEA analysis was performed at day 2 of the culture with
or without AKT activation (Figure S3F). Whereas bFGF
alone activated HDAC target genes, AKT activation sup-
pressed this gene set, indicating that AKTenhances the for-
mation of EGCs in a manner distinct from that of the
HDAC pathway.
In this study, we used target gene set analysis. We consid-
ered that this approach would allow us to understand the
gene network and epigenetic state, which are difficult to
analyze based on the individual gene expressions.WhereasStemboth PGCs and EGCs express Oct3/4, the downstream tar-
gets of OCT3/4 were repressed from days 1 to 10 (Figures
2 and S1A). This indicated that the region downstream of
OCT3/4 might differ between PGCs and EGCs. It was
previously shown that Oct3/4 plays a critical role in PGC
specification (Okamura et al., 2008). It would thus be
of interest to investigate the molecular interaction
between Oct3/4 and the factors that are important for
PGC specification, such as Blimp-1 and Prdm14. We also
applied this approach to epigenetic modifications. First,
we analyzed the histone modification-associated active
genes (H3K36me3, H3K79me2, and H3K4me3) (Marson
et al., 2008; Mikkelsen et al., 2007). The targets of these
modifications were also gradually upregulated (Figure S1B).
On the other hand, another set ofmodification targets con-
sisting of H3K4me3, H3K27me3, or both (i.e., the Bivalent
domain targets) showed intriguing change (Figure S1C).
Whereas the targets of the Bivalent domain were upregu-
lated in EGCs compared with early culture periods,
the H3K27me3 targets were repressed. The targets of
H3K4me3 were maintained in an active state. With respect
to the targets of DNAmethylation, three different gene sets
of 5hmC and two different gene sets of 5meC were
collected from three different papers (Pastor et al., 2011;
Borgel et al., 2010; Guibert et al., 2012). Except for one
time point (EGCs of Figure S1E), both the 5hmC and
5mC targets were activated from the early phase of the cul-
ture (Figures S1D–S1F). PGCs contain DNAwith a low level
of methylation (Seki et al., 2005). Therefore, it is feasible
that the targets of DNAmethylation in ESCs are already hy-
pomethylated in PGCs and so easy for the early activation.
To understand how pluripotency is achieved, we
compared somatic cell reprogramming with the acquisi-
tion of pluripotency in PGCs. Although these two phe-
nomena are different, the obtained pluripotent stem cells
have similar characteristics. Analysis of how pluripotent
stem cells are generated from different cell types might
help to clarify the mechanism of reprogramming. Of
note, PGCs already havemany similarities with pluripotent
stem cells. Both processes showed two distinct waves of
gene expression changes, in the early and late phases
(Polo et al., 2012). During somatic cell reprogramming,
both waves showed similar patterns of upregulated and
downregulated genes. In contrast, during the acquisition
of pluripotency in PGCs, the first and second waves were
mainly composed of upregulated and downregulated
genes, respectively (Figure 1E). These oppositely regulated
genes are associated with the GO terms cell cycle, develop-
ment, and metabolism (Table S1). In the early phase of
somatic cell reprogramming, genes associated with ‘‘gain
of proliferation’’, ‘‘transient activation of developmental
regulators’’, and ‘‘metabolic changes’’ are regulated (Polo
et al., 2012). Genes that are oppositely regulated duringCell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The Authors 121
the conversion of PGCs to EGCs might have an important
role in somatic cell reprogramming. Furthermore, in both
cases, cells lost their original characteristics during the early
phase, after which genes in the pluripotency-associated
network were upregulated. Comparison of these two types
of pluripotency induction would improve our understand-
ing of the reprogramming mechanisms and characteristics
of PGCs. Taken together with the results of our previous
study (Nagamatsu et al., 2012a), these findings summarize
the process of acquisition of pluripotency in PGCs
(Figure 7I).
This study presents precise information on gene expres-
sion profiles during the acquisition of pluripotency in
PGCs. This information, in turn, provides mechanistic in-
sights into the difference between PGCs and pluripotent
stem cells and can be used to investigate the mechanism
underlying somatic cell reprogramming. In future studies,
it would be useful to compare distinct cell types and mech-
anisms to better understand the germ cell characteristics
and reprogramming machinery.EXPERIMENTAL PROCEDURES
Isolation and Culture of PGCs
PGCs were purified and cultured as described previously (Naga-
matsu and Suda, 2013), and the detail is described in the Supple-
mental Information.
Microarray Analysis
Microarray analysis was performed using Whole Mouse Genome
Oligo Microarray 44K (Agilent Technologies), and the detailed in-
formation is described in the Supplemental Information.
Generation and Isolation of ESCs Expressing Germ
Cell Genes
Germ cell factors were introduced into EBRTcH3 ESCs as described
in a previous report (Masui et al., 2005), and the detail is described
in the Supplemental Information.
Teratoma Formation and Alkaline Phosphatase
Staining
Teratoma formation and alkaline phosphatase staining were per-
formed as described previously (Nagamatsu et al., 2012a), and
the detail is described in the Supplemental Information.
Antibodies
The monoclonal antibodies used for western blotting were rabbit
anti-MBD3 (ab157464; Abcam) and rabbit anti-b-ACTIN (A-2066;
Sigma).
iPSC Generation
AKT-mer MEFs were reprogrammed using Oct3/4, Sox2, and Klf4 as
described previously (Nagamatsu et al., 2012b). 4OHTwas added at
day 2 and allowed to react to day 6 after the three-factor induction.122 Stem Cell Reports j Vol. 5 j 111–124 j July 14, 2015 j ª2015 The AuthorThe numbers of morphologically ESC-like colonies were counted
at day 22.
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